Treatment of osteoporosis is aimed to prevent fragility fractures and to stabilize or increase bone mineral density. Several drugs with different efficacy and safety profiles are available. The long-term therapeutic strategy should be planned, and the initial treatment should be selected according to the individual site-specific fracture risk and the need to give the maximal protection when the fracture risk is highest (i.e. in the late life). The present consensus focused on the strategies for the treatment of postmenopausal osteoporosis taking into consideration all the drugs available for this purpose. A short revision of the literature about treatment of secondary osteoporosis due both to androgen deprivation therapy for prostate cancer and to aromatase inhibitors for breast cancer was also performed. Also premenopausal females and males with osteoporosis are frequently seen in endocrine settings. Finally particular attention was paid to the tailoring of treatment as well as to its duration.

Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis / Vescini, F.; Attanasio, R; Balestrieri, Antonio; Bandeira, F.; Bonadonna, S.; Camozzi, V.; Cassibba, S.; Cesareo, R.; Chiodini, I.; Francucci, C. Maria; Gianotti, L.; Grimaldi, F.; Guglielmi, R.; Madeo, Bruno; Marcocci, C.; Palermo, A.; Scillitani, A.; Vignali, E.; Rochira, Vincenzo; Zini, M.. - In: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. - ISSN 0391-4097. - STAMPA. - 39:(2016), pp. 807-834. [10.1007/s40618-016-0434-8]

Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis

BALESTRIERI, Antonio;MADEO, Bruno;ROCHIRA, Vincenzo;
2016

Abstract

Treatment of osteoporosis is aimed to prevent fragility fractures and to stabilize or increase bone mineral density. Several drugs with different efficacy and safety profiles are available. The long-term therapeutic strategy should be planned, and the initial treatment should be selected according to the individual site-specific fracture risk and the need to give the maximal protection when the fracture risk is highest (i.e. in the late life). The present consensus focused on the strategies for the treatment of postmenopausal osteoporosis taking into consideration all the drugs available for this purpose. A short revision of the literature about treatment of secondary osteoporosis due both to androgen deprivation therapy for prostate cancer and to aromatase inhibitors for breast cancer was also performed. Also premenopausal females and males with osteoporosis are frequently seen in endocrine settings. Finally particular attention was paid to the tailoring of treatment as well as to its duration.
2016
11-mar-2016
39
807
834
Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis / Vescini, F.; Attanasio, R; Balestrieri, Antonio; Bandeira, F.; Bonadonna, S.; Camozzi, V.; Cassibba, S.; Cesareo, R.; Chiodini, I.; Francucci, C. Maria; Gianotti, L.; Grimaldi, F.; Guglielmi, R.; Madeo, Bruno; Marcocci, C.; Palermo, A.; Scillitani, A.; Vignali, E.; Rochira, Vincenzo; Zini, M.. - In: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. - ISSN 0391-4097. - STAMPA. - 39:(2016), pp. 807-834. [10.1007/s40618-016-0434-8]
Vescini, F.; Attanasio, R; Balestrieri, Antonio; Bandeira, F.; Bonadonna, S.; Camozzi, V.; Cassibba, S.; Cesareo, R.; Chiodini, I.; Francucci, C. Maria; Gianotti, L.; Grimaldi, F.; Guglielmi, R.; Madeo, Bruno; Marcocci, C.; Palermo, A.; Scillitani, A.; Vignali, E.; Rochira, Vincenzo; Zini, M.
File in questo prodotto:
File Dimensione Formato  
0070_Vescini_et_al_JEI_2016.pdf

Open access

Descrizione: Article published by JENI
Tipologia: Versione pubblicata dall'editore
Dimensione 664.31 kB
Formato Adobe PDF
664.31 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1103529
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 35
  • ???jsp.display-item.citation.isi??? 32
social impact